Skip to Main Content

Patient-derived xenograft models of rare estrogen receptor-positive ovarian cancers

Molecular and Functional Characterization of a Patient-Derived Organoid Platform for Ovarian Cancer

Exploring a new therapeutic approach for rare ovarian cancers

Understanding and targeting single-stranded DNA gap-filling mechanisms to improve chemotherapy response

Investigating the “surfaceome” to discover new treatments for rare ovarian cancers

Understanding how glycosylated antitumour ether lipids (GAELs) kill chemotherapy-resistant cancer cells

Remodeling the immune microenvironment of ovarian cancer using oncolytic viruses

Metabolic engineering of CAR-T cells to overcome immune suppression

Optimizing an off-the shelf ovarian cancer RNA vaccine

Fallopian imaging and lavage for early-stage tubo-ovarian cancer detection